Onderneming Tiziana Life Sciences PLC Nasdaq
Aandelen
TLSA
US88875G1013
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 9
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 11-02-98 |
Keeren Shah
DFI | Director of Finance/CFO | 47 | - |
Vaseem Palejwala
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-17 |
Matthew Davis
COO | Chief Operating Officer | - | 01-07-22 |
Paul Spencer
IRC | Investor Relations Contact | - | 01-12-22 |
William Clementi
PRN | Corporate Officer/Principal | - | 01-09-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John Brancaccio
BRD | Director/Board Member | 76 | 01-07-20 |
Willy Simon
BRD | Director/Board Member | 72 | 01-11-15 |
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 11-02-98 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 194 612 289 | 63 373 729 ( 32,56 %) | 0 | 32,56 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
ACCUSTEM SCIENCES, INC. 11.80% | 1 337 970 | 11.80% | 445 544 $ |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+33,63% | 50,85 mld. | |
-0,09% | 42,82 mld. | |
+49,62% | 42,03 mld. | |
-4,96% | 29,55 mld. | |
+11,18% | 26,11 mld. | |
-21,95% | 19,13 mld. | |
+8,61% | 13,05 mld. | |
+28,31% | 12,16 mld. | |
+24,73% | 12,08 mld. |